Ping An Healthcare and Technology (SEHK:1833) has drawn fresh attention after recent share performance, with the stock down 8% over the past month and about 21% over the past 3 months.
At a share price of HK$5.96, Ping An Healthcare and Technology has not only slipped over the past month, it has also seen its 1-year total shareholder return decline 66.12%, which signals fading momentum as investors reassess both growth prospects and risk.
Compare Ping An Healthcare and Technology's slide with other potential rebound candidates by scanning our curated list of 184 high quality undervalued stocks that combine quality fundamentals with compressed expectations.
Given Ping An Healthcare and Technology's sharp retreat and compressed share price, some investors may see a reset in expectations, while others prefer to wait. The next step is to test whether the current valuation already reflects that caution.
Preferred P/E of 23.7x: Is it justified?
Valuation screens currently flag Ping An Healthcare and Technology as trading at a P/E of 23.7x, which looks cheap against selected peers on 41.1x but expensive versus both its own fair P/E estimate of 12.1x and the broader Hong Kong Consumer Retailing group on 20.8x.
The P/E ratio compares the share price with earnings per share and helps you see how much investors are paying today for each unit of profit. For a healthcare platform like Ping An Healthcare and Technology, which sits between consumer services and technology enabled medical access, P/E often becomes a shorthand for how confident the market is in the durability of earnings.
Ping An Healthcare and Technology is described as good value compared with its peer average on 41.1x. This suggests expectations for the company are set lower than for similar stocks that currently command higher earnings multiples. At the same time, the stock is described as expensive against an estimated fair P/E of 12.1x, as well as against the Hong Kong Consumer Retailing industry on 20.8x. This signals the valuation could shift if sentiment or earnings delivery move closer to that fair ratio level.
Explore the SWS fair ratio for Ping An Healthcare and Technology.
Result: Price-to-earnings of 23.7x (ABOUT RIGHT)
Still, Ping An Healthcare and Technology faces potential pressure if its recent revenue and net income growth rates slow, or if competition in online healthcare services intensifies and squeezes profitability.
Find out about the key risks to this Ping An Healthcare and Technology narrative.
Another view on Ping An Healthcare and Technology's value
While the P/E of 23.7x paints Ping An Healthcare and Technology as only mildly rich against the Hong Kong Consumer Retailing group on 20.8x, the SWS DCF model points a very different way. On that cash flow view, a fair value of HK$21.15 versus a HK$5.96 price screens as heavily undervalued and raises the question of which signal investors should trust.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ping An Healthcare and Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 184 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Sentiment around Ping An Healthcare and Technology is clearly split, which is exactly when fresh data matters most and quick decisions can shape outcomes. To weigh up both the risks and the potential upside on your own terms, start with the 3 key rewards and 1 important warning sign.
Looking for more Ping An Healthcare and Technology style ideas?
If Ping An Healthcare and Technology has you reassessing your watchlist, this is the moment to widen your net and pressure test new opportunities using the Simply Wall Street Screener.
- Target potential bargains by scanning a curated 184 high quality undervalued stocks where strong fundamentals meet compressed expectations.
- Prioritise resilience with a list of solid balance sheet and fundamentals (207 results) that can help you focus on financially sturdy businesses when conditions get tougher.
- Get ahead of the crowd by searching a focused pool of 619 high quality undiscovered gems before attention and pricing catch up.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com